Key Takeaways
- Edible oil "perfect storm" drove a ₹450 Cr EBITDA loss: A sequence of macro shocks (Indonesia export ban, Russia-Ukraine war, China zero-COVID, dollar strength) caused palm and soya prices to collapse mid-quarter, producing ₹200 Cr of realized losses and ₹250 Cr of mark-to-market unrealized losses.
- Food business integration delivered a one-off margin windfall: Revenue surged to ~₹2,400 Cr on the Patanjali Ayurved acquisition, and Diwali demand pushed segment margin to 25.9%, a level management calls unsustainable and expects to normalize to 15–18%.
- The balance sheet took a hit but is already healing: Operating cash flow turned negative on trade receivables from the food business rollout, and MTM losses have substantially recovered post-quarter as palm rebounded 18–20% and soya rose ~24%.
- Management is betting the oil shock was a 20-year event: The company is adding hedges on BMD and Chicago exchanges, sees no big challenge in Q3/Q4, and targets a return to 4% edible oil margins and consistent volume growth of 5–7%.
- What to watch next quarter: Whether the food business margin normalizes toward the 15–18% guided range, how much of the ₹200 Cr realized oil loss is actually recovered, and if the new nutraceutical direct channel sustains its ₹300–350 Cr contribution.
The Edible Oil Shock: What Happened and What's Left
- A "perfect storm" of macro events: Indonesia's palm oil export ban and rumors drove palm to $1,350/tonne; the Russia-Ukraine war pushed soya to $1,500/tonne. When Indonesia lifted the ban, a Ukraine grain corridor opened, China locked down on zero-COVID, the dollar strengthened, and the ringgit fell 5.5%, prices collapsed: palm to $840, soya to $1,200, sun oil down ~Rs. 40,000/tonne.
- Two layers of losses: ₹200 Cr of realized losses were booked during the quarter on every invoice and sale, while ₹250 Cr of mark-to-market unrealized losses sat on the books at September 30, covering purchase contracts, vessels afloat, and physical inventory.
- Post-quarter recovery is material but incomplete: By November 10, palm had recovered from $840 to $1,015 (up 18–20%), soya from $1,200 to $1,485, and sun oil up ~$300, so a substantial part of the MTM position has reversed.
- Industry-wide damage: Significant listed and unlisted competitors faced the same problems; even pure-play FMCG companies had this challenge, so the quarter reflects a sector event rather than company-specific execution failure.
- Risk management is being hardened: The company has increased hedges on BMD (palm oil) and Chicago (soya oil) exchanges, is continuously churning positions, ensuring consistent selling at all points, and moving sun oil positions consistently, with board-driven policy and daily MTM tracking plus weekly calls.
- The business can absorb normal volatility but not this: Management estimates the edible oil business, which typically earns 4% margin, can handle price movements of 4–8%; anything more than that, especially when sudden, exceeds its capacity to manage.
Asthana: "It was a perfect storm why the prices from where they went suddenly they collapsed."
Food Business Integration: A Windfall Quarter, Not a Run Rate
- Revenue jumped on acquisition close: The Patanjali Ayurved food business was integrated from July 1, contributing ₹1,241 Cr of pure acquired revenue in Q2, plus honey/atta (₹192 Cr) and soya/TSP (₹169 Cr), taking total food revenue to ~₹2,400 Cr.
- Diwali drove an exceptional margin: Overall food margin hit 25.9% (28.8% on the acquired portion) because festive demand allowed premium pricing and new direct channel benefits kicked in. Management is explicit this will not be sustained.
- Normalization path: The acquired business was taken over at 15% margin; the effort is to lift it closer to 18%. The expected run rate is 15–18%, possibly touching 20% in some quarters, but the 25.9% print was a one-off.
- Growth ambition is steady: The acquired portion should grow 10–15% consistently, adding ~₹600 Cr to revenue annually, with at least 15–20% year-on-year growth targeted.
- Cash generation potential is large: If the run rate and margin targets are maintained, management expects the food business to become a very big cash generator for the company overall.
- Credit extension hit cash flow: The food business went directly to consumer markets and had to extend credit to distributors and super-distributors, driving the trade receivables increase and negative operating cash flow; some of that receivable may be sustained for a year but should be recovered by the last quarter of this financial year.
Asthana: "Overall margin of 25.9% or thereabout that we have on the food business will this be sustained probably the answer is that it will be to huge challenge to maintain this kind of momentum."
Nutraceuticals: A Bumper Quarter With a Sustainability Question
- Revenue and margin surged: Nutraceuticals delivered ₹400 Cr of revenue with ~35% EBITDA margin, driven by consistent selling and new direct channel openings that added at least ₹300–350 Cr of business.
- The new channel is unproven: Management needs to see repeat orders and follow-through this quarter to determine sustainability; a better perspective will emerge by the end of Q3 or after Q4.
- Full-year target is ₹700–800 Cr: The company wants to maintain a 10–15% growth run rate in a market growing at almost 20%, but acknowledges that maintaining the exact Q2 quarterly sales level would be very difficult going forward.
- Biscuit margin compressed: Last quarter margin was 5.5% versus a typical 8–10%, because while sugar was stable, oil and wheat prices were high.
Edible Oil: The Case for Keeping It
- Volume growth is intact: The quarterly run rate increased from 1.25–1.35 lakh tonnes/month to ~1.5 lakh tonnes/month, with Q2 year-on-year volume growth of more than 10%. The target is to maintain 4.5 lakh tonnes/quarter and possibly add 5–7% growth.
- Margin target is 4%: Management's objective is a 4% margin (typical range 2–4%), with 5% on the higher side. At 4% margin and six capital turns per year, the implied return is 24%, which management cites as the reason no demerger is needed.
- Q3 and Q4 look reasonable: The lag from October is largely behind; all business is now occurring at the same margin levels, and no further inventory loss is expected for the balance of Q3.
- Loss recovery is a best-effort goal: Management is making its "best effort" to recover the ₹200 Cr realized loss and says a "good window is available," but committing to full recovery "would be a little exaggeration." The ₹250 Cr MTM position is already "way better" than at September 30.
- No demerger, no matter the valuation argument: An analyst pressed the case that the food business could generate PAT of ₹1,500–2,000 Cr in 1–2 years while edible oil volatility hampers valuation. Management flatly declined, citing distribution synergies, shared teams, cost structure, infrastructure, and healthy return on capital in edible oil.
Asthana: "If we can rotate this capital even six times a year and we make on an average let us say 4% margin you are talking about 24% return so there is no requirement at this stage. We do not feel any compelling reason... for Patanjali Foods, edible oils is very critical and important segment. We would like to retain that and grow that."
Balance Sheet and Cash Flow: Damage and Repair
- Operating cash flow turned negative: The swing was driven by credit extended to customers upon introduction of the food business; management states it has since been recovered and full-year cash flow should be positive.
- Trade receivables swelled: The major contribution came from the food business going direct to consumer markets and extending credit to distributors and super-distributors, with some contribution from the oil business as well. Some of the amount may be sustained for a year but should be recovered within the last quarter of this financial year.
- Food business credit period may compress: The credit period might come down depending on the business scenario.
- Disclosure is improving: Management agreed to include quarterly volume numbers in disclosures for the oil business going forward.
The One-Off Thesis and What It Means for FY24
- Events without precedent in 20 years: Management characterizes the quarter's oil shock as a series of events happening simultaneously that have not occurred for 20 years, with no likelihood they will recur.
- FY24 EBITDA target: ₹2,200–2,400 Cr: Food is expected to contribute ~50% of company profits from a margin contribution perspective, with turnover closer to ~25% of total.
- Oil plantation and new products are being built: Massive work is ongoing on the oil plantation side, with expansion of new products and hiring of business heads and leaders in place.
- Revenue and margin consistency is the goal: Management is taking all necessary steps to get the company back to a consistent run rate of revenues and margin, maintaining a healthy run rate on the revenue side.
Asthana: "I would like to summarize... one off events in a particular quarter which were unprecedented in scale and suddenness that has had an impact on the company's bottom line which we are absolutely certain that which will not repeat themselves again. Of course one cannot ever predict future as to how this will go but an event which has not occurred for 20 years or series of events happening at the same time there is no likelihood that they will recur again..."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Edible oil margin normalization | Return to 4% margin (2–4% typical range) | Q3/Q4 FY23 onward |
| Edible oil volume growth | Maintain 4.5 lakh tonnes/quarter; 5–7% growth on top | Q3 FY23 and ongoing |
| Food business margin normalization | Taper from 25.9% to 15–18% run rate (effort to reach 18%) | Ongoing from Q3 FY23 |
| Food business revenue growth | Acquired portion to grow 10–15% consistently; at least 15–20% YoY | Ongoing |
| Nutraceutical full-year revenue | ₹700–800 Cr | FY23 |
| FY24 company EBITDA | ₹2,200–2,400 Cr | FY24 |
| FY24 food profit contribution | ~50% of company profits | FY24 |
| Operating cash flow | Positive on full-year basis | FY23 |
| Trade receivables recovery | Recovered within the last quarter of this financial year | Q4 FY23 |
| Quarterly volume disclosure | Include volume numbers in oil business disclosures | Going forward |
Key Metrics
| Metric | Q2 FY23 |
|---|---|
| Revenue | ₹8,500 thousand Crores |
| EBITDA | ~₹205 Crores |
| PAT | ₹112 Crores |
| Oil and vanaspati segment revenue | ~₹5,900 Crores |
| Oil and vanaspati segment EBITDA | Negative ₹450 Crores, 7.63% margin |
| Foods business revenue | ~₹2,400 Crores |
| Foods business EBITDA | ₹460 Crores, 28.8% margin |
| Foods business overall margin | 25.9% |
| Nutraceuticals revenue | ₹400 Crores |
| Nutraceuticals EBITDA | ~₹140 Crores, ~35% margin |
| Acquired food business from PAL revenue | ₹1,241 Crores |
| Acquired food business from PAL margin | 25.5% |
| Biscuit business revenue | Almost ₹350 Crores |
| Biscuit business margin | 5.5%, typically 8–10% |
| Realized losses booked in edible oil during quarter | ₹200 Crores |
| Mark-to-market losses at end of September quarter | ₹250 Crores |
| Edible oil sales volume growth YoY | More than 10% |
| Edible oil monthly volume run rate | 1.5 lakh tonnes, previously 1.25–1.35 lakh tonnes |
| Edible oil volume target | 4.5 lakh tonnes per quarter, with 5–6% growth |
| Trade receivables as of September 30, 2022 | ~₹2,000 Crores, up from ₹796 Crores on March 31, 2022 |
| Oil business credit period | 22 to 25 days |
| Food business credit period | 1 to 1.5 months |
| FY24 EBITDA target | ₹2,200 to ₹2,400 Crores |
| Food business FY24 margin contribution target | About 50% of company profits |
| Nutraceuticals full-year FY23 revenue target | ₹700 to ₹800 Crores |
| New channel revenue contribution in quarter | At least ₹300 to 350 Crores |
| Food business revenue growth target | 15–20% year-on-year |
| Food business margin target | Closer to 18%, taken over at 15% |
| Edible oil normalized margin target | 2% to 4%, objective of 4% |
| Food business acquisition price | ₹690 Crores |